SDS

Safety Data Sheet
ReMARKable Water Based Dry-Erase - CLEARRESIN PART B
Revision date: 2018/07/24
!
6"|"Page!
!
!
!
!
!
!
Oral
Type of value: LD50 Species: rat
Value: > 5,000 mg/kg (OECD Guideline 401)
No mortality was observed.
Inhalation
Type of value: LC50 Species: rat
Value: > 5.8 mg/l (OECD Guideline 403) Exposure time: 4 h
No mortality was observed.
Dermal
Type of value: LD50 Species: rat
Value: > 2,000 mg/kg (OECD Guideline 402) No mortality was observed.
Assessment other acute effects Assessment of STOT single:
Based on the available information there is no specific target organ toxicity to be expected after a single
exposure.
Irritation / corrosion
Assessment of irritating effects: Not irritating to the skin. Not irritating to the eyes.
Skin
Species: rabbit Result: non-irritant
Method: OECD Guideline 404
Eye
Species: rabbit Result: non-irritant
Method: OECD Guideline 405
Sensitization
Assessment of sensitization: Caused skin sensitization in animal studies.
Guinea pig maximization test Species: guinea pig
Result: sensitizing
Method: OECD Guideline 406
Aspiration Hazard not applicable
Chronic Toxicity/Effects
Repeated dose toxicity
Assessment of repeated dose toxicity: The substance may cause damage to the liver after repeated ingestion.
Effect found in rodents only. The relevance to humans is questionable. Due to the species specific mode of
action, the effects are not expected to occur in humans.
Genetic toxicity
Assessment of mutagenicity: The substance was not mutagenic in bacteria. The substance was not mutagenic
in mammalian cell culture. The substance was not mutagenic in studies with mammals.
Carcinogenicity
Assessment of carcinogenicity: No data was available concerning carcinogenic activity.